Latest Series B Funding Rounds

Startups financing expansion after their early institutional rounds. Explore the businesses, round sizes and investors behind the next phase.

This page showsStage: Series B
Rounds
589
All time
Disclosed funding
$58.6B
500 disclosed amounts
Median round
$46.8M
Of disclosed amounts
589 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
Black Forest LabsAI · GermanyCompany profile

Black Forest Labs develops generative AI models for visual creation and enterprise applications.

Black Forest Labs develops generative AI models for visual creation and enterprise applications.

$300MSeries BAIGermanyInvestors
Sakana AIAI · JapanCompany profile

Sakana AI is a Tokyo research company developing nature-inspired AI models and methods.

Sakana AI is a Tokyo research company developing nature-inspired AI models and methods.

~¥32BSeries B cumulative, updated 9 April 2026Series BAIJapanInvestors
LangChainAI · United StatesCompany profile

LangChain builds open-source frameworks and the LangSmith platform for developing, running and improving AI agents.

LangChain builds open-source frameworks and the LangSmith platform for developing, running and improving AI agents.

$125MSeries BAIUnited StatesInvestors
Kailera TherapeuticsBiotech · United StatesCompany profile

Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms.

Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms.

$600MSeries BBiotechUnited StatesInvestors
KardiganBiotech · United StatesCompany profile

Kardigan develops cardiovascular medicines that target specific biological drivers of heart disease and the patient groups most likely to respond.

Kardigan develops cardiovascular medicines that target specific biological drivers of heart disease and the patient groups most likely to respond.

$254MSeries BBiotechUnited StatesInvestors
Surv BioPharmaBiotech · JapanCompany profile

Surv BioPharma develops oncolytic virus therapies for cancer.

Surv BioPharma develops oncolytic virus therapies for cancer.

¥1.5BSeries B first closeSeries BBiotechJapanInvestors
Neptune RoboticsRobotics · SingaporeCompany profile

Neptune Robotics provides underwater robotic cleaning and inspection services to commercial shipowners.

Neptune Robotics provides underwater robotic cleaning and inspection services to commercial shipowners.

$52MSeries BRoboticsSingaporeInvestors
NscaleAI · United KingdomCompany profile

Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference

Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference

$1.1BSeries BAIUnited KingdomInvestors
Reexen TechnologyHardware · ChinaCompany profile

Reexen Technology develops compute-in-memory chips and systems for AI inference.

Reexen Technology develops compute-in-memory chips and systems for AI inference.

>CN¥100MSeries BHardwareChinaInvestors
RevyveFoodtech · NetherlandsCompany profile

Revyve produces yeast protein ingredients for food manufacturers.

Revyve produces yeast protein ingredients for food manufacturers.

~€24MSeries BFoodtechNetherlandsInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    Y Combinator (YC)

    Model ML, Garage, Infisical

    23rounds
    0led
  2. 2
    General Catalyst

    Rox, Hypersonica, Collective

    23rounds
    8led
  3. 3
    Khosla Ventures

    Traversal, Even Healthcare, Arena

    23rounds
    6led
  4. 4
    Andreessen Horowitz (a16z)

    Tutor Intelligence, Town, Arena

    22rounds
    4led
  5. 5
    Sequoia Capital

    Rox, Traversal, Nevis

    20rounds
    4led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic